|
1
|
Hecker M, Zaslona Z, Kwapiszewska G, Niess
G, Zakrzewicz A, Hergenreider E, Wilhelm J, Marsh LM, Sedding D,
Klepetko W, et al: Dysregulation of the IL-13 receptor system: A
novel pathomechanism in pulmonary arterial hypertension. Am J
Respir Crit Care Med. 182:805–818. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Galiè N, Humbert M, Vachiery JL, Gibbs S,
Lang I, Torbicki A, Simonneau G, Peacock A, Noordegraaf Vonk A,
Beghetti M, et al: 2015 ESC/ERS Guidelines for the diagnosis and
treatment of pulmonary hypertension: The Joint Task Force for the
Diagnosis and Treatment of Pulmonary Hypertension of the European
Society of Cardiology (ESC) and the European Respiratory Society
(ERS) Endorsed by: Association for European Paediatric and
Congenital Cardiology (AEPC), International Society for Heart and
Lung Transplantation (ISHLT). Eur Heart J. 37:67–119. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Qiao S, Fan K, Iwashita T, Ichihara M,
Yoshino M and Takahashi M: The involvement of reactive oxygen
species derived from NADPH oxidase-1 activation on the constitutive
tyrosine auto-phosphorylation of RET proteins. Free Radic Res.
48:427–434. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Schermuly RT, Ghofrani HA, Wilkins MR and
Grimminger F: Mechanisms of disease: Pulmonary arterial
hypertension. Nat Rev Cardiol. 8:443–455. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cunha SI, Pardali E, Thorikay M, Anderberg
C, Hawinkels L, Goumans MJ, Seehra J, Heldin CH, ten Dijke P and
Pietras K: Genetic and pharmacological targeting of activin
receptor-like kinase 1 impairs tumor growth and angiogenesis. J Exp
Med. 207:85–100. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gore B, Izikki M, Mercier O, Dewachter L,
Fadel E, Humbert M, Dartevelle P, Simonneau G, Naeije R, Lebrin F
and Eddahibi S: Key role of the endothelial TGF-β/ALK1/endoglin
signaling pathway in humans and rodents pulmonary hypertension.
PLoS One. 9:e1003102014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Girerd B, Montani D, Coulet F, Sztrymf B,
Yaici A, Jaïs X, Tregouet D, Reis A, Drouin-Garraud V, Fraisse A,
et al: Clinical outcomes of pulmonary arterial hypertension in
patients carrying an ACVRL1 (ALK1) mutation. Am J Respir Crit Care
Med. 181:851–861. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Goumans MJ, Liu Z and ten Dijke P:
TGF-beta signaling in vascular biology and dysfunction. Cell Res.
19:116–127. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
López-Novoa JM and Bernabeu C: The
physiological role of endoglin in the cardiovascular system. Am J
Physiol Heart Circ Physiol. 299:H959–H974. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Santibañez JF, Quintanilla M and Bernabeu
C: TGF-β/TGF-β receptor system and its role in physiological and
pathological conditions. Clin Sci (Lond). 121:233–251. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Albro MB, Nims RJ, Durney KM, Cigan AD,
Shim JJ, Vunjak-Novakovic G, Hung CT and Ateshian GA: Heterogeneous
engineered cartilage growth results from gradients of
media-supplemented active TGF-β and is ameliorated by the
alternative supplementation of latent TGF-β. Biomaterials.
77:173–185. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
López-Hernández FJ and López-Novoa JM:
Role of TGF-β in chronic kidney disease: An integration of tubular,
glomerular and vascular effects. Cell Tissue Res. 347:141–154.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tanjore H, Blackwell TS and Lawson WE:
Emerging evidence for endoplasmic reticulum stress in the
pathogenesis of idiopathic pulmonary fibrosis. Am J Physiol Lung
Cell Mol Physiol. 302:L721–L729. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chaumais MC, Ranchoux B, Montani D,
Dorfmüller P, Tu L, Lecerf F, Raymond N, Guignabert C, Price L,
Simonneau G, et al: N-acetylcysteine improves established
monocrotaline-induced pulmonary hypertension in rats. Respir Res.
15:652014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Idrees MM, Saleemi S, Azem MA, Aldammas S,
Alhazmi M, Khan J, Gari A, Aldabbagh M, Sakkijha H, Aldalaan A, et
al: Saudi guidelines on the diagnosis and treatment of pulmonary
hypertension: 2014 updates. Ann Thorac Med. 9 Suppl 1:S1–S15. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuan P, Wu WH, Liu D, Zhang R and Jing ZC:
Determination of pulmonary vascular resistance by improved right
heart catheter in rat. Zhonghua Xin Xue Guan Bing Za Zhi.
39:901–904. 2011.(In Chinese). PubMed/NCBI
|
|
17
|
Good RB, Gilbane AJ, Trinder SL, Denton
CP, Coghlan G, Abraham DJ and Holmes AM: Endothelial to mesenchymal
transition contributes to endothelial dysfunction in pulmonary
arterial hypertension. Am J Pathol. 185:1850–1858. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Evans JD, Girerd B, Montani D, Wang XJ,
Galiè N, Austin ED, Elliott G, Asano K, Grünig E, Yan Y, et al:
BMPR2 mutations and survival in pulmonary arterial hypertension: An
individual participant data meta-analysis. Lancet Respir Med.
4:129–137. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takahashi J, Orcholski M, Yuan K and de
Jesus Perez V: PDGF-dependent β-catenin activation is associated
with abnormal pulmonary artery smooth muscle cell proliferation in
pulmonary arterial hypertension. FEBS Lett. 590:101–109. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sarrion I, Milian L, Juan G, Ramon M,
Furest I, Carda C, Gimeno Cortijo J and Roig Mata M: Role of
circulating miRNAs as biomarkers in idiopathic pulmonary arterial
hypertension: Possible relevance of miR-23a. Oxid Med Cell Longev.
2015:7928462015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cogan JD, Pauciulo MW, Batchman AP, Prince
MA, Robbins IM, Hedges LK, Stanton KC, Wheeler LA, Phillips JA III,
Loyd JE and Nichols WC: High frequency of BMPR2 exonic
deletions/duplications in familial pulmonary arterial hypertension.
Am J Respir Crit Care Med. 174:590–598. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McLaughlin VV, Archer SL, Badesch DB,
Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH,
Rosenson RS, et al: ACCF/AHA 2009 expert consensus document on
pulmonary hypertension: A report of the American College of
Cardiology Foundation Task Force on Expert Consensus Documents and
the American Heart Association: Developed in Collaboration With the
American College of Chest Physicians, American Thoracic Society,
Inc., and the Pulmonary Hypertension Association. Circulation.
119:2250–2294. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Morine KJ, Qiao X, Paruchuri V, Aronovitz
MJ, Mackey EE, Buiten L, Levine J, Ughreja K, Nepali P, Blanton RM,
et al: Conditional knockout of activin like kinase-1 (ALK-1) leads
to heart failure without maladaptive remodeling. Heart Vessels.
32:628–636. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mishra A, Stueckle TA, Mercer RR, Derk R,
Rojanasakul Y, Castranova V and Wang L: Identification of TGF-β
receptor-1 as a key regulator of carbon nanotube-induced
fibrogenesis. Am J Physiol Lung Cell Mol Physiol. 309:L821–L833.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mitchell D, Pobre EG, Mulivor AW, Grinberg
AV, Castonguay R, Monnell TE, Solban N, Ucran JA, Pearsall RS,
Underwood KW, et al: ALK1-Fc inhibits multiple mediators of
angiogenesis and suppresses tumor growth. Mol Cancer Ther.
9:379–388. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jerkic M, Kabir MG, Davies A, Yu LX,
McIntyre BA, Husain NW, Enomoto M, Sotov V, Husain M, Henkelman M,
et al: Pulmonary hypertension in adult Alk1 heterozygous mice due
to oxidative stress. Cardiovasc Res. 92:375–384. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Eyries M, Coulet F, Girerd B, Montani D,
Humbert M, Lacombe P, Chinet T, Gouya L, Roume J, Axford MM, et al:
ACVRL1 germinal mosaic with two mutant alleles in hereditary
hemorrhagic telangiectasia associated with pulmonary arterial
hypertension. Clin Genet. 82:173–179. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen L, Xiao J, Li Y and Ma H: Ang-(1–7)
might prevent the development of monocrotaline induced pulmonary
arterial hypertension in rats. Eur Rev Med Pharmacol Sci. 15:1–7.
2011.PubMed/NCBI
|
|
29
|
Xi Y, Tan K, Brumwell AN, Chen SC, Kim YH,
Kim TJ, Wei Y and Chapman HA: Inhibition of
epithelial-to-mesenchymal transition and pulmonary fibrosis by
methacycline. Am J Respir Cell Mol Biol. 50:51–60. 2014.PubMed/NCBI
|
